Biogen Advances Tau Alzheimer’s Treatment to Phase 3 Following Mid-Stage Setback, Stirring Tentative Hope

Biogen Advances Tau Alzheimer’s Treatment to Phase 3 Following Mid-Stage Setback, Stirring Tentative Hope